US Bancorp’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.41K Sell
692
-9
-1% -$70 ﹤0.01% 3542
2026
Q1
$4.46K Buy
701
+35
+5% +$244 ﹤0.01% 3606
2025
Q4
$4.69K Hold
666
﹤0.01% 3557
2025
Q3
$3.66K Sell
666
-36,252
-98% -$178K ﹤0.01% 3624
2025
Q2
$191K Buy
36,918
+5,200
+16% +$31.2K ﹤0.01% 2044
2025
Q1
$211K Buy
31,718
+29,900
+1,645% +$227K ﹤0.01% 1964
2024
Q4
$13.4K Hold
1,818
﹤0.01% 3305
2024
Q3
$12.7K Hold
1,818
﹤0.01% 3276
2024
Q2
$8.93K Hold
1,818
﹤0.01% 3353
2024
Q1
$11.2K Sell
1,818
-834
-31% -$5.62K ﹤0.01% 3297
2023
Q4
$20.8K Hold
2,652
﹤0.01% 3033
2023
Q3
$18.2K Hold
2,652
﹤0.01% 2927
2023
Q2
$24.2K Hold
2,652
﹤0.01% 2886
2023
Q1
$19.7K Buy
2,652
+2,222
+517% +$12.3K ﹤0.01% 3003
2022
Q4
$2.12K Buy
+430
New +$2.66K ﹤0.01% 3755

Other funds holding LFST

US Bancorp's LFST Position: Q2 2026 in Review

US Bancorp reduced its Lifestance Health (LFST) stake by 1.3% in Q2 2026, selling an estimated $70 and leaving 692 shares worth $7.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

US Bancorp first reported a position in LFST in Q4 2022 and has held it in 15 quarters since. The position peaked at $211K in Q1 2025. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • US Bancorp held 692 shares of Lifestance Health worth $7.41K as of Q2 2026.
  • US Bancorp sold 9 Lifestance Health shares in Q2 2026, an estimated $70.
  • Lifestance Health made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3542 holding.
  • US Bancorp first reported a position in Lifestance Health in Q4 2022 and has held it in 15 quarters since.
  • US Bancorp's Lifestance Health position peaked at $211K in Q1 2025.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.